Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PhytoSERM for Menopausal Hot Flashes
NCT06186531Phase 2Recruiting
- Sponsor
- NeuTherapeutics
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by NeuTherapeutics. Primary endpoint: Hot Flash Composite score. Started Nov 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06186531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06186531.